CORC

在结果中检索

CORC

浏览/检索结果: 共482条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Development and Realization of a Q-band Receiver 会议论文
Fuzhou, Fujian, China, 13-16 Dec. 2020
作者:  Wang, Kai;  Ning, Yun-Wei;  Yan, Hao;  Cao, Liang;  Ma, Jun
收藏  |  浏览/下载：50/0  |  提交时间：2021/06/18
Research and Analysis on Energy Consumption of Underwater Hexapod Robot Based on Typical Gait 会议论文
Yantai, China, October 22-25, 2021
作者:  Ma XF(马秀峰);  Zhang QF(张奇峰);  Sun YZ(孙英哲);  Wang N(王宁)
收藏  |  浏览/下载：25/0  |  提交时间：2021/11/08
Augmented System Observer-based Robust Fault-estimation Scheme for Nonlinear Systems 会议论文
Shanghai, China, July 26-28, 2021
作者:  Gao S(高升);  Ma GF(马广富);  Guo YN(郭延宁);  Zhang W(张伟)
收藏  |  浏览/下载：12/0  |  提交时间：2021/10/30
黄玉的高温/高压同步辐射X射线衍射和拉曼光谱研究 会议论文
中国重庆, 2020-10-18
作者:  黄仕杰;  许金贵;  李博;  叶之琳;  陈伟
收藏  |  浏览/下载：34/0  |  提交时间：2021/11/11
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Analysis on nonlinear characters of built-in sensor in smart device under the condition of voice actuating 会议论文
作者:  Zhao, Ning;  Shen, Junjie;  Ma, Xiaolin;  Liu, Yuhe
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Expression atlas of FGF and FGFR genes in pan-cancer uncovered predictive biomarkers for FGFR inhibition response in clinical trials 会议论文
作者:  Li, Yuan;  Wu, Long;  Cheng, Yanlei;  Tao, Weiping;  Wu, Dawei
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace